Department of Orthopaedic Surgery and Duke Clinical Research Institute, Duke University, Durham, North Carolina.
Transl Res. 2021 Aug;234:129-140. doi: 10.1016/j.trsl.2021.04.006. Epub 2021 Apr 24.
Chronic back and neck pain are highly prevalent conditions that are among the largest drivers of physical disability and cost in the world. Recent clinical practice guidelines recommend use of non-pharmacologic treatments to decrease pain and improve physical function for individuals with back and neck pain. However, delivery of these treatments remains a challenge because common care delivery models for back and neck pain incentivize treatments that are not in the best interests of patients, the overall health system, or society. This narrative review focuses on the need to increase use of non-pharmacologic treatment as part of routine care for back and neck pain. First, we present the evidence base and summarize recommendations from clinical practice guidelines regarding non-pharmacologic treatments. Second, we characterize current use patterns for non-pharmacologic treatments and identify potential barriers to their delivery. Addressing these barriers will require coordinated efforts from multiple stakeholders to prioritize evidence-based non-pharmacologic treatment approaches over low value care for back and neck pain. These stakeholders include patients, health care providers, health care organizations, administrators, payers, policymakers and researchers.
慢性腰背颈疼痛是高度普遍的病症,是世界上导致身体残疾和医疗成本最高的疾病之一。最近的临床实践指南建议使用非药物治疗来减轻疼痛和改善腰背颈疼痛患者的身体功能。然而,这些治疗方法的实施仍然具有挑战性,因为腰背颈疼痛的常见护理模式鼓励使用不符合患者、整个医疗体系或社会最佳利益的治疗方法。本综述重点介绍了增加非药物治疗作为腰背颈疼痛常规护理一部分的必要性。首先,我们提出了证据基础,并总结了临床实践指南中关于非药物治疗的建议。其次,我们描述了非药物治疗的当前使用模式,并确定了其实施的潜在障碍。解决这些障碍需要来自多个利益相关者的协调努力,将基于证据的非药物治疗方法置于腰背颈疼痛的低价值护理之上。这些利益相关者包括患者、医疗保健提供者、医疗保健组织、管理人员、支付方、政策制定者和研究人员。